Skip to content

Alinity m 09N43-095Recalls & reported problems

Abbott Molecular Inc. · Alinity m EBV AMP Kit · Class 2

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00884999049505), received between Feb 27, 2023 and Jan 20, 2026 — classified as 2 malfunctions.

The most frequently reported specific device problem is “False Negative Result” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 1 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • False Negative Result1
  • False Positive Result1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 20, 2026False Negative Result

    THE CUSTOMER REPORTED FALSE NOT DETECTED RESULTS ON THE ALINITY M EBV AMP KIT. THE CUSTOMER REPORTED 1 PATIENT HAD 2 FALSE NOT DETECTED RESULTS: SAMPLE ID (SID) (B)(6) WAS "NOT DETECTED" FOR EBV-PLASMA PROTOCOL ON (B)(6) 2025. IN ADDITION SID (B)(6) (VIRAL LOAD OF 1479 IU/ML FOR WHOLE BLOOD) WAS "NOT DETECTED" FOR EBV-PLASMA ON (B)(6) 2025 AS WELL. THE PATIENT HAS A CHRONIC T-CELL EBV INFECTION AND HAS BEEN POSITIVE WITH COMPARABLE VALUES SINCE (B)(6) 2025 (CONFIRMED THROUGH REFERENCE LAB IN PARIS). THE CUSTOMER IS ALLEGING THAT ALL NOT DETECTED RESULTS FOR THAT PATIENT ARE QUESTIONED AS THE PATIENT HAS A KNOWN EBV INFECTION CONSTANTLY SHOWING SINCE (B)(6) 2025 (ALSO IN SEROLOGY). BASED ON THIS INFORMATION PROVIDED, THE CUSTOMER IS ALLEGING DISCREPANT FALSE NOT DETECTED RESULTS ON EBV-PLASMA (LIST NUMBER 09N43-91) FOR SID (B)(6) AND SID (B)(6).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24121824 ↗
  • MalfunctionFeb 27, 2023False Positive Result; False Positive Result

    THE CUSTOMER REPORTED DISCREPANT (FALSE DETECTED) ALINITY EBV RESULTS WITH LOWER LIMIT OF QUANTIFICATION (LLOQ). SAMPLE ID, ALINITY RESULT, DATE, MAYO RESULT : (B)(6). MAYO RESULTS WERE GENERATED USING AN ALTERNATIVE PLATFORM (ROCHE MOLECULAR). THERE WAS NO IMPACT TO PATIENT MANAGEMENT FOR THE SAMPLE IDS LISTED ABOVE. MAYO RESULTS WERE RELEASED TO PROVIDER. THE REPORTED EVENT WAS CONSIDERED FALSE DETECTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16450192 ↗

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.